Mads Jarner Brevadt co-founded Radiobotics in 2017 and served as CEO until 2023, when he transitioned into the role of Chief Operating Officer. Following Radiobotics' 2026 merger with Medimaps, he serves at Chief Product and Technology Officer at Medimaps.
Before founding Radiobotics, Mads worked as a Research Assistant and Data Scientist in the MSk Lab at Imperial College London, a multidisciplinary research lab focused on improving musculoskeletal health — particularly within orthopaedics — where he contributed to several peer-reviewed publications and presented work at international conferences.
He also worked as a Surgical Planner at Embody Orthopaedic in London, and as an R&D Engineer at CathVision, a Copenhagen-based start-up developing recording equipment for catheter ablation procedures.
Mads also serves as a Board Member at Erhvervshus Hovedstaden, a Danish regional business development agency.
Education
Master's degree in Medicine & Technology, Technical University of Denmark (DTU); additional coursework in Bioengineering and Biomedical Engineering, UC Berkeley